p300 Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of p300 monoclonal antibodies for investigating p300 protein activity in various cellular processes. The monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). p300 protein functions as a crucial co-activator in gene expression regulation, playing a significant role in cellular signaling pathways and transcriptional activation. Its activity is essential in processes such as cell growth, differentiation, and response to external stimuli, making p300 an important target for research in cancer and other diseases. Understanding p300 mechanisms can provide insights into therapeutic strategies and the development of targeted treatments. Researchers worldwide rely on p300 monoclonal antibodies to advance their studies in cell biology, cancer research, and drug development. p300 monoclonal antibodies enable reproducible results across multiple experimental applications. Santa Cruz Biotechnology monoclonal antibodies for p300 continue to support breakthrough discoveries in cellular and molecular biology research.